TCL Archive Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial? January 5, 1996
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive In Brief: William Longmire Replaces Fisher On Cancer Panel; Talbot Urges Organizations To Avoid Polarization July 9, 1982
